July 9, 2020 / 11:19 AM / 25 days ago

BRIEF-ProMIS Neurosciences And BC Neuroimmunology Announce Revenue-Sharing Joint Venture Agreement To Develop And Offer Blood-Based Diagnostic Tests For Alzheimer's Disease

July 9 (Reuters) - ProMIS Neurosciences Inc:

* PROMIS NEUROSCIENCES AND BC NEUROIMMUNOLOGY ANNOUNCE REVENUE-SHARING JOINT VENTURE AGREEMENT TO DEVELOP AND OFFER BLOOD-BASED DIAGNOSTIC TESTS FOR ALZHEIMER’S DISEASE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below